Objective-Studying the underlying molecular mechanisms for maintaining stereotyped vascular lumen diameters should help toward a comprehensive understanding of vascular homeostasis and function. We aimed to determine the role of SH3-domain GRB2-like 3 (Sh3gl3) and its interacting pathways in dorsal aorta (DA) maintenance in zebrafish. Approach and Results-Sh3gl3 and its binding partner, Cbl-interacting protein of 85K (Cin85), together regulate endocytosis and were expressed in the developing vasculature. Morpholino knockdown of either gene resulted in shrinkage of the DA lumen, although artery/vein specification and the initial formation of vascular lumens were unaffected. in addition, sh3gl3 and cin85 morpholinos exerted a synergistic effect in causing the vascular phenotypes. To identify the signaling pathways in which Sh3gl3/Cin85 may participate, we screened several candidate inhibitors for their ability to induce similar circulatory defects. Chemical inhibition of the epidermal growth factor receptor and the phosphatidylinositol 3-kinase/Akt cascade led to a loss of circulation and shrunken DA in zebrafish embryos. Furthermore, inhibition of the epidermal growth factor receptor/phosphatidylinositol 3-kinase pathway showed a functional cooperation with Sh3gl3 deficiency in impairing DA lumens.
T he formation and maintenance of vascular lumens by endothelial cells (ECs) are essential for normal vascular function. Lumen size greatly impacts blood flow, blood pressure, and perfusion of tissues. However, the molecular mechanisms controlling the maintenance of blood vessel lumens are largely unknown, possibly because of the fact that early defects in vasculogenesis or angiogenesis usually impair lumen formation as well. 1 Temporally controlled approaches, therefore, are required to elucidate mechanisms that specifically regulate vascular lumen size. The zebrafish seems to be a model system especially amenable to such investigation. Zebrafish embryos can survive and develop for ≈7 days without any blood circulation, providing a unique opportunity to examine lumen maintenance defects that usually cause lethality in mammalian embryos. 2 Zebrafish embryos can be easily subjected to small-molecule chemical/drug treatment at designated time points. Furthermore, several EC-specific transgenic zebrafish lines have been generated using the kdrl or fli1a promoter, which facilitate real-time monitoring and recording of blood vessel maintenance in live embryos under a fluorescence microscope. 3, 4 Recently, a zebrafish protein SH3-domain GRB2-like 3 (Sh3gl3) was identified as a potential regulator of blood vessel lumen maintenance. 5 Morpholino knockdown of Sh3gl3 caused a significant reduction in the diameter of the dorsal aorta (DA) in zebrafish embryos at 72 hours post fertilization (hpf). The mammalian SH3GL3, also referred to as endophilin A3 and extra eleven nineteen (EEN)-B2, belongs to a small family of SH3 domain containing proteins. SH3GL proteins are thought to regulate clathrin-coated vesicle formation by modifying membrane phospholipids and inducing negative curvature and invagination of the plasma membrane during the early steps of endocytosis. 6, 7 Mammalian SH3GL3 proteins, which are preferentially expressed in the brain and testis, selectively interact with synaptojanin, dynamin, and exon 1 of the huntingtin protein. [7] [8] [9] Several in vitro studies have demonstrated that mammalian SH3GL3/endophilin A3 is constitutively associated with the adaptor protein Cblinteracting protein of 85K (CiN85). The endophilin-CiN85 complex is recruited by the ubiquitin ligase Cbl to activated receptor tyrosine kinases, which subsequently promotes the internalization of these receptors. [10] [11] [12] To date, the in vivo function of SH3GL3 has yet to be addressed.
in the current study, we demonstrate that Sh3gl3 and Cin85 play a critical synergistic role in vascular lumen maintenance in zebrafish embryos. Furthermore, chemical inhibition of the epidermal growth factor receptor (EGFR) or the phosphatidylinositol 3-kinase (Pi3K)/Akt signaling cascade showed a functional cooperation with Sh3gl3 deficiency in impairing blood vessel lumens, suggesting a possible involvement of Sh3gl3-Cin85 in the EGFR/Pi3K signaling pathways.
Materials and Methods
Materials and Methods are available in the online-only Supplement. A full description of materials and methods used, including wholemount in situ hybridization, morpholino knockdown, microangiography, RNA synthesis and injection, vibratome sections, measurement of DA diameter, chemical treatments, Western blots, and quantitative reverse transcriptase-polymerase chain reaction, is available in the online-only Data Supplement.
Results

Knockdown of Sh3gl3 Causes Collapse of Vascular Lumens
Zebrafish Sh3gl3 protein contains 386 amino acids and displays 59% identity (73% similarity) to the human SH3GL3 (endophilin A3). Protein alignment and phylogenic analysis revealed the existence of another ortholog of mammalian SH3GL3, Zgc158742, in zebrafish embryos (Figure iA in the online-only Data Supplement). However, the expression of this homolog seemed to be ubiquitous, and no specific expression was observed in the vasculature. in contrast, sh3gl3 RNA was specifically expressed in vascular ECs and their precursors. At the 12-somite stage, sh3gl3 RNA was localized in 2 stripes of cells within the lateral mesoderm, likely EC precursors (Figure iC in the online-only Data Supplement). By 26 hpf, sh3gl3 expression peaked in the entire vasculature, including major axial, head, and intersegmental vessels. 5 At 36 hpf, vascular sh3gl3 was mostly restricted to axial vessels and at lower levels to the cardinal vein plexus region (Figure iD in the online-only Data Supplement).
Subsequently, 2 different sh3gl3-specific morpholinos were used to knockdown the function of Sh3gl3. injection of either morpholino resulted in similar circulatory defects, while having no effect on overall body morphology ( Figure 1A ). Most embryos injected with 5 ng sh3gl3 morpholino-1 showed no circulation and developed pericardial edema between 48 and 72 hpf, and eventually became necrotic and died. Microangiography with fluorescein-labeled dextran showed the dye remaining in the heart region and not entering the blood vessels in sh3gl3 morphants ( Figure 1B ), although the heart morphology was unaffected. A closer examination of the axial vessels using Tg(kdrl:GFP) transgenic fish embryos revealed a significant decrease in the DA diameter in sh3gl3 morphants (arrow in Figure 1C ' compared with 1C, Figure 1G ), implying lumen size reduction. Furthermore, vibratome cross-sections confirmed that sh3gl3 morpholino indeed affected vascular lumens, as the DA lumen was almost absent ( Figure 1D ). As shown in Figure Expression of both the arterial marker efnb2a and the venous marker flt-4 seemed normal at 33 hpf, indicating that the initial specification of the arterial/venous identity was unaffected by Sh3gl3 deficiency (Figure 1E and 1F ). Previous studies have demonstrated that the definitive hematopoietic stem cells originate from the ventral wall of the DA in zebrafish embryos. 13 Here, we also analyzed the expression of c-myb and rag-1 in sh3gl3 morpholino-1-injected embryos. c-myb expression was significantly reduced in sh3gl3 morphants at 34 hpf. Similarly, rag-1 expression was greatly downregulated in response to sh3gl3 morpholinos (Figure iii in the online-only Data Supplement). These results further suggested that the integrity of the DA was compromised by the knockdown of Sh3gl3 function.
To determine whether the effects of sh3gl3 morpholino on DA lumen maintenance were secondary to lack of circulation, we carried out a closer examination of the cardiac function and circulation of sh3gl3 morphants. First, the contractile function of the heart indicated by heartbeat rate was not significantly affected by sh3gl3 morpholino-1 at either 32 or 48 hpf (Figure iVA in the online-only Data Supplement). in addition, the initial blood flow in sh3gl3 morphants seemed comparable with controls. Blood flow abnormality and DA defects became evident at 48 hpf. Next, we compared tnnt2a/sih morphants, 14, 15 which lack heartbeats, with sh3gl3 morphants. injection of 1 ng of tnnt2a/sih morpholino resulted in loss of circulation. Like sh3gl3 morpholinos, tnnt2a morpholino did not alter the initial arterial/venous specification and vascular lumen formation in zebrafish embryos. it seemed that vascular lumen expansion, which may occur between 26 and 40 hpf in wild-type zebrafish embryos, did not take place in tnnt2a morphants. By 72 hpf, tnnt2a morphants displayed collapse of the entire vasculature. DA, posterior cardinal vein, and intersomitic vessel lumens were all severely affected (Figure iVB in the online-only Data Supplement). in contrast, sh3gl3 morpholino had more specific effects on DA diameter. Because sh3gl3 morphants had normal heartbeat rate before 48 hpf, we also used a myosin-ATPase inhibitor 2, 3-butanedione-2-monoxime to temporarily arrest the heartbeat and circulation of zebrafish embryos. 4, 16 We observed that temporary 2, 3-butanedione-2-monoxime treatment (15 mmol/L, from 48 to 72 hpf) did not lead to any significant DA defects (Figure iVC in the online-only Data Supplement). Moreover, we examined the expression level of sh3gl3 gene in tnnt2a morphants. Knockdown of tnnt2a apparently did not alter sh3gl3 expression either at 32 or at 48 hpf (Figure iVD in the onlineonly Data Supplement).
Cin85, the Binding Partner of Sh3gl3, Is Also Involved in Vascular Lumen Maintenance
To investigate the underlying mechanism of Sh3gl3 function in zebrafish vasculature, we identified the zebrafish homolog of CiN85 (XM_002666661) and examined its role during fish embryonic development. Whole mount in situ hybridization analysis showed that cin85 was expressed in 2 stripes of cells within the intermediate mesoderm at 14-somite stage ( Figure  2A ). Later at 36 hpf, cin85 transcripts were detected in the notochord, axial blood vessels, and the cardinal vein plexus region-very similar to sh3gl3 at this developmental stage (Figure 2A' ). injection of a cin85-specific morpholino (6 ng) resulted in a loss of circulation, pericardial edema ( Figure 2B ), and greatly reduced DA lumen size ( Figure 2C , 2G, and 2H), without affecting the morphology and contractile function of the heart. Furthermore, morpholino knockdown of both Sh3gl3 and Cin85 revealed a synergistic effect on vascular lumen maintenance ( Figure 2D-2F) . At a subeffective dosage of either morpholino alone, there was no effect on axial blood vessels ( Figure 2D and 2E ). However, the simultaneous inhibition of both factors at the same subeffective doses significantly reduced the diameter of the DA in >70% of the injected embryos (58/82). These results strongly suggest that Sh3gl3 and Cin85 cooperate to regulate vascular lumen maintenance in developing zebrafish embryos.
Because previous in vitro studies have demonstrated that mammalian SH3GL3/endophilin A3 and CiN85 function primarily through endocytosis regulation, [10] [11] [12] we subsequently tested whether inhibition of endocytosis could elicit any vascular defects in zebrafish embryos. We found that embryos exposed to phenylarsine oxide, an inhibitor of clathrin-dependent endocytosis, 17, 18 exhibited circulation defects and pericardial edema, similar to sh3gl3/cin85 morphants. Phenylarsine oxide introduction at 3 to 5 μmol/L at 28 or 36 hpf resulted in a significant decrease in DA diameter at 72 hpf (41 out of 47 embryos, Figure V in the online-only Data Supplement).
EGFR/PI3K Pathway Is Possibly Involved in Sh3gl3-mediated DA Lumen Maintenance
Vascular endothelial growth factor (VEGF), the master regulator of angiogenesis, has also been shown to regulate lumen size of capillaries. 1, 19, 20 it is likely that Sh3gl3 and Vegf may function in a common or converging pathway in zebrafish vascular development. To explore this possibility, we tested whether SU5416, a potent and selective inhibitor of VEGF signaling, could also reduce lumen size like sh3gl3 morpholinos. As shown in Figure Vi in the online-only Data Supplement, SU5416 treatment (2.5 μmol/L and 5 μmol/L) did not produce the thinner DA phenotype when added to fish embryos at 26, 30, 36, and 48 hpf, respectively. in addition, we found that sh3gl3 mRNA overexpression did not rescue arterial/venous differentiation defects caused by chemical inhibition of VEGF signaling (SU5416 5 μmol/L). Furthermore, ectopic induction of arterial marker expression (Efnb2a) by vegf overexpression did not require Sh3gl3 function (data not shown). These studies indicate that the function of Sh3gl3 in vascular lumen maintenance is independent of Vegf signaling. Wild-type embryos were injected with 4 ng of control morpholino (A) or sh3gl3 morpholino-1 (A') and analyzed at 48 hours post fertilization (hpf). Sh3gl3 morphants looked normal, except for blood cells stuck at the sinus venous. B, Microangiography analysis of the circulatory system in sh3gl3 morphants at 48 hpf. Note that sh3gl3 morpholino-1 led to a complete loss of circulation (B'). C, Knockdown of Sh3gl3 caused DA to reduce. Tg(kdrl:GFP) embryos were injected with 4 ng of control morpholino (C) or sh3gl3 morpholino-1 (C'), and lateralview confocal images were taken at 72 hpf. The trunk region above the yolk extension is shown. White arrows point to the DA. D, Sh3gl3 morpholino caused DA lumen to collapse. Tg(kdrl:GFP) embryos were injected with 5 ng of control morpholino (D) or sh3gl3 morpholino-1 (D'), fixed at 72 hpf, cross-sectioned and imaged with a confocal microscope. White arrows point to DA lumen. E, Expression of the venous marker flt-4 appeared normal in sh3gl3 morphants (E') compared with control embryos (E) at 33 hpf. F, Expression of the arterial marker efnb2a was unaffected by sh3gl3 morpholino at 33 hpf. Wild-type embryos were injected with 4 ng of control morpholino (E and F) or sh3gl3 morpholino-1 (E' and F'). G, DA diameter was significantly reduced in sh3gl3 morphants. Tg(kdrl:GFP) embryos were injected with 4 ng of control morpholino or sh3gl3 morpholino-1. DA diameter was measured at 72 hpf from confocal images, and the data from all the embryos in 1 group were averaged and shown as mean±SE. Sample sizes were n=10 for the control group and n=20 for sh3gl3 morphants. Double asterisks indicate significant difference (P<0.01, Student t test).
To identify the signaling pathways in which Sh3gl3 may participate, we subsequently examined selected chemical inhibitors of various pathways, including Hedgehog, BMP, EGF, wingless/integrated (Wnt), and Pi3K, for their ability to induce circulatory defects similar to those of sh3gl3 morphants. inhibitor names and treatment conditions are listed in Table i in the online-only Data Supplement. The screen identified the Pi3K inhibitor LY294002 and EGFR inhibitor AG1478 as positive hits.
EGFR is known to be an upstream activator of Pi3K. Moreover, Cbl-CiN85-endophilin (SH3GL3) complex has been reported to be capable of promoting the internalization of activated EGFR in mammalian cell lines. [10] [11] [12] Thus, it is likely that Sh3gl3 functions through regulating the endocytosis of Egfr protein in zebrafish vasculature. To test this hypothesis, we first checked the expression pattern of egfra in developing zebrafish embryos by whole mount in situ hybridization. From 18-somite to 36 hpf, when sh3gl3 was expressed in the vasculature, a ubiquitous distribution of a low level of egfra RNA was detected throughout the embryo (data not shown). When Tg(kdrl:GFP) transgenic embryos were exposed to 20 μmol/L LY294002 at 26 or 30 hpf, significant reduction of DA diameter was observed by 54 hpf (Figure 3A and 3E) . Moreover, chemical inhibition of Pi3K signaling by another potent inhibitor, wortmannin (0.2 μmol/L), produced similar DA defects, suggesting the specificity of these effects ( Figure  ViiiA On the other hand, AG1478 treatment (2 μmol/L) at 26 hpf resulted in similar DA shrinkage by 72 hpf (Figure 4A and 4E) . Egfr inhibition by AG1478 and sh3gl3 morpholino-1 had a synergistic effect on reducing DA lumen size ( Figure 4B-4D) . We subsequently obtained an egfra-specific morpholino and confirmed that knockdown of Egfra function by morpholino injection (5 ng) also led to significant reduction of DA diameter in >70% of the morphants (Figure iXA and iXB in the online-only Data Supplement). Combined use of subeffective doses of sh3gl3 morpholino-1 (2 ng) and egfra morpholino (2 ng) greatly reduced DA diameter as well (Figure iXC-iXE in the online-only Data Supplement). in addition, Akt phosphorylation level was downregulated in embryos treated with sh3gl3 morpholino-1 ( Figure 3F ), cin85 morpholino ( Figure  X in the online-only Data Supplement), or AG1478 ( Figure  4F ), respectively, further implying the involvement of EGFR/ Pi3K/Akt in Sh3gl3 function.
Discussion
Previous studies have indicated that the SH3GL/CiN85/Cbl complex regulates the internalization of activated receptor tyrosine kinases, including EGFR, in mammalian cell culture systems. [10] [11] [12] in this report, we demonstrate that zebrafish sh3gl3 is specifically expressed in the developing vasculature, and that knockdown of Sh3gl3 function results in the collapse of the DA lumen without affecting the initial arterial/venous specification and vascular lumen formation in zebrafish embryos. it is quite unlikely that the vascular lumen defects in sh3gl3 morphants are because of the absence of blood flow and blood pressure. As a factor involved in endocytosis, Sh3gl3 is specifically expressed in the vasculature, not in the heart or blood cells. Knockdown of Sh3gl3 did not alter the Wild-type embryos were injected with 6 ng of control morpholino (B) or cin85 morpholino (B') and analyzed at 48 hpf. C, Cin85 morpholino greatly reduced the diameter of DA. Tg(kdrl:GFP) embryos were injected with 6 ng of control morpholino (C) or cin85 morpholino (C'), and confocal images were taken at 72 hpf. D-F, Cin85 and Sh3gl3 function synergistically in DA lumen maintenance. Embryos injected with 3 ng of cin85 morpholino (D) or 2 ng of sh3gl3 morpholino-1 (E) had a normal DA, whereas combined use of both morpholinos effectively induced a thinner DA (F). White arrows point to the DA. G, Cin85 morpholino caused DA lumen to collapse. Tg(kdrl:GFP) embryos were injected with 6 ng of control morpholino (G) or cin85 morpholino (G'), fixed at 76 hpf, cross-sectioned, and imaged with a confocal microscope. White arrows point to DA lumen. H, DA diameter was significantly reduced in cin85 morphants. Tg(kdrl:GFP) embryos were injected with control morpholino or cin85 morpholino, and DA diameter was measured at 72 hpf. Sample sizes were n=10 for the control group and n=15 for cin85 morphants. Double asterisks indicate significant difference (P<0.01, Student t test). morphology or the contractile function of the heart. in addition, the initial blood flow in sh3gl3 morphants seemed comparable with controls. Blood flow abnormality and DA defects became evident at 48 hpf. Furthermore, we obtained tnnt2a/sih morphants, which lack heartbeats and blood circulation, and observed vascular phenotypes distinct from those of sh3gl3 morphants. Not surprisingly, knockdown of tnnt2a/sih did not cause significant change in sh3gl3 expression at either 32 or 48 hpf. Together, these data indicate that Sh3gl3 plays a crucial role in vascular lumen maintenance in zebrafish.
As a factor involved in endocytosis of various activated receptor tyrosine kinases, including EGFR, Sh3gl3 may participate in regulation of cell survival and cell-junction maintenance. Given the fact that sh3gl3 is specifically expressed in the vasculature in zebrafish embryos, Sh3gl3 function might be important for EC survival in particular. Whole-mount in vivo apoptosis assay could be performed to determine whether inhibition of Sh3gl3 function causes abnormal cell death in the DA. Alternatively, knockdown of Sh3gl3 may affect the integrity of EC junctions and thus cause the DA to collapse. Electron microscopy analysis would help reveal the potential ultrastructural changes of ECs in the DA of sh3gl3 morphants.
We have also provided 3 lines of genetic evidence, suggesting that Sh3gl3 possibly functions through the EGFR/Pi3K pathway to maintain vascular lumens in zebrafish. First, we showed that Cin85 deficiency caused vascular defects similar to sh3gl3 morphants, and Cin85 functioned synergistically with Sh3gl3 in DA lumen maintenance. Subsequently, we uncovered the involvement of Pi3K, an important effector of EGFR signaling, in vascular lumen maintenance. inhibition of Pi3K signaling by 2 structurally unrelated chemical inhibitors, after the establishment of arterial/venous specification, also caused defective circulation and severe DA lumen reduction. The inhibitory effect seemed to synergize with Sh3gl3 deficiency. in addition, knockdown of Sh3gl3 function greatly downregulated Akt phosphorylation. The function of Pi3K in DA lumen maintenance is unexpected, because Pi3K/Akt signaling has been shown to promote a venous fate in zebrafish. 21 Our results suggest that Pi3K may play distinct roles at multiple stages during zebrafish vascular development. Finally, chemical inhibition of zebrafish Egfr signaling or knockdown of Egfra function by morpholino injection also led to a loss of circulation and significant DA lumen reduction, and had a synergistic effect with sh3gl3 morpholino during the process.
Although our results support the involvement of EGFR/ Pi3K pathway in Sh3gl3-mediated DA maintenance, we cannot rule out the possibility that EGFR/Pi3K and Sh3gl3 might be functioning in independent pathways. Several in vitro studies in mammalian cell lines have shown that Sh3gl3/Endophilin A3 and Cin85 affect endocytic trafficking of EGFR. 11, 12 To demonstrate the direct involvement of Sh3gl3/Cin85 in Egfr endocytosis in vivo, we would like to examine whether endogenous Sh3gl3/Cin85 and Egfr proteins colocalize with certain endosome markers, such as Rab5 and Rab7, in fish embryos. Alternatively, multiple zebrafish transgenic lines for these factors could be generated and manipulated to demonstrate the direct interaction in future studies. in addition, effective rescue of the DA defects in sh3gl3 morphants by inhibition with LY294002 resulted in a shrunken DA similar to sh3gl3 morpholinos. Tg(kdrl:GFP) embryos were exposed to LY294002 (20 μmol/L) at 26 hours post fertilization (hpf) and analyzed at 54 hpf. B-D, PI3K inhibition and sh3gl3 morpholino-1 had a synergistic effect on reducing DA lumen size; 5 μmol/L of LY294002 (B) or 1.5 ng of sh3gl3 morpholino-1 (C) alone failed to produce any circulation/ DA phenotype. However, application of both treatments caused a great reduction of the DA diameter (D). E, DA diameter was significantly decreased in LY294002treated embryos. Tg(kdrl:GFP) embryos were exposed to 20 μmol/L LY294002 at 26 hpf, and DA diameter was measured at 54 hpf. Sample sizes were n=10 for the control group and n=16 for LY294002treated embryos. Double asterisks indicate significant difference (P<0.01, Student t test). F, Akt phosphorylation was reduced in sh3gl3 morphants. Wildtype embryos were injected with 4 ng of sh3gl3 morpholino-1, collected at 54 hpf, and subjected to Western blot analysis of total Akt and phospho-Akt. LY294002treatment (20 μmol/L, 26-54 hpf) was used as a positive control.
Pi3K activation would indeed prove the involvement of Pi3K in Sh3gl3 function. We are currently in search of antibodies that could specifically recognize Sh3gl3, Cin85, or Egfr in vivo, and appropriate Pi3K activators that could elevate Pi3K/ Akt signaling in a timely manner in fish embryos.
Although the involvement of EGFR signaling in tumor angiogenesis has been intensively documented, its function in normal vascular development remains largely unknown. Our data raise the possibility that EGFR signaling regulates the maintenance of blood vessel lumens through the Pi3K/Akt cascade. Goishi et al 22 previously reported that inhibition of zebrafish Egfr activity resulted in dilated heart chambers and impeded blood flow into the DA. Here, we observed collapse of DA lumens in addition to enlarged hearts on Egfr inhibition. More importantly, combined use of subeffective doses of the EGFR inhibitor and sh3gl3 morpholino led to DA shrinkage without significant dilation of the heart, suggesting that the cardiac phenotype could be secondary to blood vessel lumen reduction.
Numerous studies have been done to address the mechanisms of EGFR endocytosis and its roles in EGFR signaling, producing several nonreconcilable models of these processes. [23] [24] [25] it has been reported that binding of EGF to EGFR results in rapid internalization of activated receptors and targeting of internalized EGF-receptor complexes to lysosomes for degradation; additionally, several in vitro studies indicate that the SH3GL/CiN85/Cbl complex promotes the internalization and subsequent downregulation of activated EGFR. However, activated EGFR can continue to send signals from endosomes. 23, [26] [27] [28] [29] For instance, endocytosis has been proposed to be necessary for the normal duration and intensity of EGFR signaling to mitogen-activated protein kinases. 28, 29 interestingly, in a recent report, Goh et al 30 generated a novel and specific internalization-defective EGFR mutant, and subsequently demonstrated that EGFR internalization is required for the sustained activation of Akt. it is possible that distinct internalization mechanisms of EGFR may contribute in different cell types and under various experimental conditions, and the outcomes of EGFR endocytosis may vary in different systems as well. Our current results suggest a possible involvement of Sh3gl3/Cin85-mediated Egfr internalization for Pi3K/ Akt activation in maintaining vascular integrity in zebrafish.
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Figure 4.
Epidermal growth factor receptor (Egfr) signaling is possibly involved in SH3-domain GRB2-like 3 (Sh3gl3)mediated dorsal aorta (DA) lumen maintenance. A, Egfr inhibition with AG1478 caused DA lumen reduction. Tg(kdrl:GFP) embryos were subjected to AG1478 treatment (2 μmol/L) at 26 hours post fertilization (hpf) and analyzed at 72 hpf. AG1478-treated embryos (A') had a DA significantly thinner than that of controls (A). B-D, Egfr inhibition and sh3gl3 morpholino-1 had a synergistic effect on reducing DA lumen size. One micromole per liter of AG1478 (B) or 2 ng of sh3gl3 morpholino-1 (C) alone did not produce any circulation/DA phenotype. However, application of both treatments caused DA shrinkage (D). E, DA diameter was significantly reduced in AG1478-treated embryos. Tg(kdrl:GFP) embryos were exposed to 2 μmol/L AG1478 at 26 hpf, and DA diameter was measured at 72 hpf. Sample sizes were n=10 for the control group and n=15 for AG1478-treated embryos. Double asterisks indicate significant difference (P<0.01, Student t test). F, Akt phosphorylation was greatly decreased in AG1478-treated embryos. Wild-type embryos were treated with 2 μmol/L AG1478 at 26 hpf, collected at 54 hpf, and subjected to Western blot analysis.
